23andMe Files for Bankruptcy Amid Concerns About Security of Customers’ Genetic Data

The New York Times – Business:

The company filed for Chapter 11 bankruptcy to “facilitate a sale process.” Its chief executive stepped down and said she would bid on it.

This post first appeared in The New York Times – Business. Read the original article.